21 October 2021 - Australians may not get access to the Novavax vaccine this year with reports of manufacturing problems causing more delays.
Australia has ordered 51 million doses of the long-awaited Novavax vaccine, which was expected to play a large role in the booster program, and was expected to begin delivery this year.